Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

by C. Bazzani, M. Frassi, P. Airò, S. Zingarelli, M. Scarsi, M. Puoti
Published 2011-09-01

Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

by P. Airò, R. Gorla, M. Vianelli, M. Frassi, E. Danieli, F. Franceschini, I. Cavazzana, R. Cattaneo
Published 2011-09-01

Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center

by F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò
Published 2018-07-01

Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I

by P.L. Meroni, T. Avcin, A. Lojacono, M. Frassi, M. Nuzzo, W.L. Binder, G.L. Norman, M. Motta, C. Nalli, L. Andreoli, A. Tincani
Published 2011-06-01

Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

by P.L. Meroni, T. Avcin, V. Medeghini, A. Meini, A. Lojacono, M. Frassi, M. Nuzzo, Z. Shums, W.L. Binder, G.L. Norman, M. Motta, L. Andreoli, C. Nalli, A. Tincani
Published 2011-09-01

Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies

by M. Frassi, A. Brucato, I. Cavazzana, F. Franceschini, D. Faden, M. Motta, A. Doria, R. Cimaz, M.P. Pisoni, M. Muscarà, G. Castellino, G. Brambilla, P.L. Meroni, R. Cattaneo, C. Biasini Rebaioli, C. Antonioli, G. Balestrieri, A. Tincani
Published 2001-12-01